GlassScriptPhysician profile
Gordon C Gunn
NPI 1194829184
$247.02
in general payments reported to CMS, 2019-2025
8 companies · $5.67 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.47 · 2020: $76.14 · 2021: $34.30 · 2022: $51.44 · 2025: $5.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $53.71 | 2019-2020 | |
| Abbvie INC. | $38.37 | 2019-2020 | |
| Novo Nordisk INC | $34.58 | 2022 | |
| Therapeuticsmd, INC. | $34.18 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $28.11 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $23.43 | 2020-2021 | |
| Allergan, INC. | $17.78 | 2019 | |
| Avion Pharmaceuticals | $16.86 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Gunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.